Vaccines targeting the highly transmissible delta variant may now be needed given its ability to infect people with fading immunity and potentially increased severity, researchers leading a large English study of COVID-19 shots have said.
A third wave of English cases has been driven by the delta strain among both unvaccinated people — especially those between the ages of 12 and 24 — as well as some people who had received COVID-19 shots, according to authors of a study of samples from about 98,000 people in England. The effectiveness of vaccines at stopping infection during the study period fell to 49%, the researchers estimated, down from 64% in a month earlier. Vaccines’ protection against development of COVID-19 symptoms was 59%, down from 83%.
"Development of vaccines against delta may be warranted,” in the light of evidence that the strain’s spike protein has mutated to a point where antibodies raised by current shots are becoming less effective, the researchers said.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.